UK Outlook 2018: IVDs Faces Up To Digital, Pathology Consolidation And IVDR Challenges

UK diagnostics manufacturers face major challenges in adapting to the EU IVDR and to the possible changes that Brexit will bring in regulation, trading conditions, costs and access to talent. In addition, the industry will have to factor in a restructuring of pathology networks and future NHS procurement changes, all while transitioning to digital health-care concepts, says IVD industry association chief Doris-Ann Williams.

binocular on the top of building

[Editor's Note: The is the final entry in our UK Outlook 2018 series, which also included an assessment of oncoming NHS procurement changesBrexit and innovation, and market access and the Accelerated Access Pathway.]

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United Kingdom

More from Europe